Molecule Details
| InChIKey | ABMQIHFTAMGDJE-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-[(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl]-23-oxo-8-oxa-1,15,17,21-tetrazapentacyclo[19.2.2.13,7.19,13.015,19]heptacosa-3,5,7(27),9,11,13(26),16,18-octaene-10-carbonitrile |
| Canonical SMILES | CC1(C)OCC(Cc2ccc3cc2CN2CCN(CC2=O)Cc2cncn2Cc2ccc(C#N)c(c2)O3)O1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.61 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile